Regulacje i polityka gospodarcza · 02/10/2025
National Center for Advancing Translational Sciences to Grant Exclusive Patent License to Stage One Immunotherapeutics
The National Center for Advancing Translational Sciences is considering granting an exclusive patent license to Stage One Immunotherapeutics, Inc. for its quinoline analogs as Aldehyde Dehydrogenase 1A1 inhibitors.